Patient Journeys - Upper Tract Urothelial Carcinoma VL

Overcoming Upper Tract Urothelial Carcinoma: Michael Miller's Journey with JELMYTO® Treatment - Michael Miller

Details
Diagnosed with upper tract urothelial carcinoma, Michael Miller is initially shaken by the possibility of losing his kidney. However, he finds a less invasive alternative with JELMYTO®, a treatment offered at the Georgia Cancer Center. The process involves six weekly infusions, with minimal discomfort and disruption to his daily life. Despite a minor infection, the procedure is smooth, and he succ...

Choosing JELMYTO®: A Patient's Journey Through Less Invasive Upper Tract Urothelial Carcinoma Treatment - Tom Murphy

Details
In the wake of being diagnosed with upper tract urothelial cancer (UTUC), patient Tom Murphy navigates through his treatment options, ultimately settling on JELMYTO® (mitomycin) treatment. This less invasive procedure consists of six weekly treatments which were, according to Murphy, relatively simple and unobtrusive to his everyday life. Expressing gratitude for the guidance and support of his me...

JELMYTO® Treatment for Upper Tract Urothelial Carcinoma and Lynch Syndrome: Patient Journey and Innovative Therapy - Michael Miller

Details
Zach Klaassen, a urologic oncologist, discusses upper tract urothelial carcinoma treatment with JELMYTO® and Lynch syndrome with his patient, Michael Miller. Mr. Miller shares his journey with Lynch syndrome, a genetic condition that increases the risk of various cancers, including colorectal, kidney, upper tract urothelial carcinoma. He discusses his previous experience with colorectal cancer and...